These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21940407)

  • 41. Best practice and future challenges for vaccination against porcine circovirus type 2.
    Segalés J
    Expert Rev Vaccines; 2015 Mar; 14(3):473-87. PubMed ID: 25400216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
    Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
    Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge.
    Seo HW; Oh Y; Han K; Park C; Chae C
    BMC Vet Res; 2012 Oct; 8():194. PubMed ID: 23078878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China.
    Li J; Yu T; Wang X; Zhou J; Gao R; Zhang F; Gao X; Gao S; Liu X
    Virol J; 2015 Jul; 12():113. PubMed ID: 26220290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
    Zhu S; Zhang C; Wang J; Wei L; Quan R; Yang J; Yan X; Li Z; She R; Hu F; Liu J
    PLoS One; 2016; 11(2):e0147432. PubMed ID: 26848967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.
    Fort M; Sibila M; Pérez-Martín E; Nofrarías M; Mateu E; Segalés J
    Vaccine; 2009 Jun; 27(30):4031-7. PubMed ID: 19379787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies.
    Haake M; Palzer A; Rist B; Weissenbacher-Lang C; Fachinger V; Eggen A; Ritzmann M; Eddicks M
    Vet Microbiol; 2014 Jan; 168(2-4):272-80. PubMed ID: 24315042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain.
    Opriessnig T; Gerber PF; Xiao CT; Mogler M; Halbur PG
    Vaccine; 2014 Jan; 32(2):230-7. PubMed ID: 24269319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of different protocols of vaccination against porcine circovirus type 2 (PCV2) in a farm affected by postweaning multisystemic wasting syndrome (PMWS).
    Pejsak Z; Podgórska K; Truszczyński M; Karbowiak P; Stadejek T
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e1-5. PubMed ID: 19910048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of a piglet-specific commercial inactivated vaccine against Porcine circovirus type 2 in clinical field trials.
    Han K; Seo HW; Oh Y; Park C; Kang I; Jang H; Chae C
    Can J Vet Res; 2013 Jul; 77(3):237-40. PubMed ID: 24101803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity.
    Fraile L; Grau-Roma L; Sarasola P; Sinovas N; Nofrarías M; López-Jimenez R; López-Soria S; Sibila M; Segalés J
    Vaccine; 2012 Mar; 30(11):1986-92. PubMed ID: 22245604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.
    Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L
    Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
    Seo HW; Park SJ; Park C; Chae C
    Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative analyses of humoral and cell-mediated immune responses upon vaccination with different commercially available single-dose porcine circovirus type 2 vaccines.
    Seo HW; Lee J; Han K; Park C; Chae C
    Res Vet Sci; 2014 Aug; 97(1):38-42. PubMed ID: 24794246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination.
    Opriessnig T; Patterson AR; Madson DM; Pal N; Ramamoorthy S; Meng XJ; Halbur PG
    Vet Microbiol; 2010 May; 142(3-4):177-83. PubMed ID: 19913369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
    Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
    Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs.
    Martelli P; Ardigò P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Luppi A; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2013 Mar; 162(2-4):558-571. PubMed ID: 23206413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 replication in utero.
    Madson DM; Patterson AR; Ramamoorthy S; Pal N; Meng XJ; Opriessnig T
    Clin Vaccine Immunol; 2009 Jun; 16(6):830-4. PubMed ID: 19357312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus.
    Ostanello F; Caprioli A; Di Francesco A; Battilani M; Sala G; Sarli G; Mandrioli L; McNeilly F; Allan GM; Prosperi S
    Vet Microbiol; 2005 Jul; 108(3-4):179-86. PubMed ID: 15916871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut microbiome associations with outcome following co-infection with porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) in pigs immunized with a PRRS modified live virus vaccine.
    Constance LA; Thissen JB; Jaing CJ; McLoughlin KS; Rowland RRR; Serão NVL; Cino-Ozuna AG; Niederwerder MC
    Vet Microbiol; 2021 Mar; 254():109018. PubMed ID: 33639341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.